JP2022517101A5 - - Google Patents

Info

Publication number
JP2022517101A5
JP2022517101A5 JP2021540415A JP2021540415A JP2022517101A5 JP 2022517101 A5 JP2022517101 A5 JP 2022517101A5 JP 2021540415 A JP2021540415 A JP 2021540415A JP 2021540415 A JP2021540415 A JP 2021540415A JP 2022517101 A5 JP2022517101 A5 JP 2022517101A5
Authority
JP
Japan
Prior art keywords
gpr156
rodent
gene
human
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021540415A
Other languages
English (en)
Japanese (ja)
Other versions
JP7509786B2 (ja
JP2022517101A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/013801 external-priority patent/WO2020150426A1/en
Publication of JP2022517101A publication Critical patent/JP2022517101A/ja
Publication of JP2022517101A5 publication Critical patent/JP2022517101A5/ja
Application granted granted Critical
Publication of JP7509786B2 publication Critical patent/JP7509786B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021540415A 2019-01-17 2020-01-16 気分障害の齧歯類モデル Active JP7509786B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962793523P 2019-01-17 2019-01-17
US62/793,523 2019-01-17
US201962899849P 2019-09-13 2019-09-13
US62/899,849 2019-09-13
PCT/US2020/013801 WO2020150426A1 (en) 2019-01-17 2020-01-16 A rodent model of mood disorders

Publications (3)

Publication Number Publication Date
JP2022517101A JP2022517101A (ja) 2022-03-04
JP2022517101A5 true JP2022517101A5 (https=) 2023-01-04
JP7509786B2 JP7509786B2 (ja) 2024-07-02

Family

ID=69529068

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021540415A Active JP7509786B2 (ja) 2019-01-17 2020-01-16 気分障害の齧歯類モデル

Country Status (11)

Country Link
US (2) US11470828B2 (https=)
EP (1) EP3911154A1 (https=)
JP (1) JP7509786B2 (https=)
KR (1) KR20210116480A (https=)
CN (1) CN113423266A (https=)
AU (1) AU2020209184A1 (https=)
CA (1) CA3124514A1 (https=)
IL (1) IL284078A (https=)
MX (1) MX2021008291A (https=)
SG (1) SG11202106423PA (https=)
WO (1) WO2020150426A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7509786B2 (ja) * 2019-01-17 2024-07-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 気分障害の齧歯類モデル
CN116676334B (zh) * 2023-02-08 2025-05-27 深圳大学 抑郁症动物模型的构建方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001004137A1 (en) 1999-07-09 2001-01-18 Genaissance Pharmaceuticals, Inc. Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
ATE437948T1 (de) * 2000-06-20 2009-08-15 Bionomics Ltd Mutation, welche mit epilepsie assoziiert ist
EP1581648A2 (en) 2002-09-09 2005-10-05 Nura, Inc. G protein coupled receptors and uses thereof
US20040216177A1 (en) 2003-04-25 2004-10-28 Otsuka Pharmaceutical Co., Ltd. Congenic rats containing a mutant GPR10 gene
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
EP1940876A1 (en) 2005-10-28 2008-07-09 Takeda Cambridge Limited Gpr 26 g-protein coupled receptor
EP2091556B1 (en) * 2006-11-15 2018-07-25 Omeros Corporation Non-human animal comprising a mutation in the sreb2/gpr85 gene as animal model of metabolic disease
US8518392B2 (en) 2009-08-14 2013-08-27 Regeneron Pharmaceuticals, Inc. Promoter-regulated differentiation-dependent self-deleting cassette
EP4502152A3 (en) * 2009-10-06 2025-04-30 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
US20160058891A1 (en) 2011-11-01 2016-03-03 Roche Glycart Ag In vivo adcc model
MX384291B (es) 2013-02-20 2025-03-14 Regeneron Pharma Modificación genética de ratas.
DK3456831T3 (da) 2013-04-16 2021-09-06 Regeneron Pharma Målrettet modifikation af rottegenom
DK3422845T3 (da) 2016-02-29 2021-08-30 Regeneron Pharma Gnavere med et humaniseret tmprss-gen
EP3491014B1 (en) 2016-07-28 2023-04-05 Regeneron Pharmaceuticals, Inc. Allele-specific primer or probe hybridized to a nucleic acid molecule encoding a gpr156 variant
JP7509786B2 (ja) * 2019-01-17 2024-07-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 気分障害の齧歯類モデル

Similar Documents

Publication Publication Date Title
TWI848486B (zh) 組織選擇性轉基因表現
CN110269047A (zh) 人源化IL-4和IL-4Rα动物
JP2017514501A5 (https=)
JP2011501652A5 (https=)
CN106282122A (zh) 一种非人哺乳动物恐惧症或其相关疾病动物模型的建立方法及其用途
JP4468429B2 (ja) ニューロンニコチン性アセチルコリン受容体のβ2−サブユニットの調節配列及びこれをコードする配列を含むゲノムDNA断片、及びこれらの断片又は突然変異断片を用いて作製されたトランスジェニック動物
JP2019505216A5 (https=)
JP5393492B2 (ja) 動物モデル、その作製方法、及び、それを用いた薬物候補のスクリーニング方法
JP2022517101A5 (https=)
US20230123787A1 (en) Rodent model of mood disorders
JP7504030B2 (ja) 進行性骨化性線維異形成症のげっ歯類モデル
JP2001500385A (ja) 組換え血管内皮増殖因子b(vegf−b)dnaによるトランスジェニック動物およびその利用方法
JP2024500153A5 (https=)
KR100699453B1 (ko) 신경퇴행성 질환용 모델로서의 형질전환 동물
WO2021070866A1 (ja) アルツハイマー病モデル非ヒト動物及びその製造方法
CN113082193B (zh) 受调节的内分泌特异性蛋白18及其基因的用途
JP2018201495A (ja) 多系統萎縮症モデル動物
JPH0851890A (ja) プロテオリピド蛋白質が欠損しているトランスジエニツク動物およびそのような動物の作製方法
CN1952159A (zh) 用于taar1功能的基因敲除动物
ES2257902B1 (es) Modelo de animal transgenico para el desarrollo de nuevas aproximaciones terapeuticas.
JP6323876B2 (ja) ノックインマウス
JP2007129938A (ja) ノックアウトマウス
JP2006314242A (ja) 哺乳動物由来の変異sdhc遺伝子を有する遺伝子組み換え動物
KR20150122373A (ko) 뇌하수체 종양 동물모델
JP2006158397A (ja) sca2遺伝子の病原性変異体を発現するF066トランスジェニックマウス